Elmiron
Product utilized to address interstitial cystitis and indicated to support the bladder lining by reducing pain and discomfort.
Strengths: 100mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Bladder Protectant
- Pharmacological class
Glycosaminoglycan
- Contraindications
hypersensitivity; active bleeding; surgery
- Minor side effects
alopecia; nausea; diarrhoea; headache
- Moderate side effects
rash; abdominal pain; abnormal liver function
- Dosage forms
Capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Janssen
- Onset Time
4–12 weeks
- Duration
constant throughout therapy
- Storage instructions
Store at room temperature in a dry container, away from light and heat.
- Drug interactions
anticoagulants; antiplatelet agents
- Age restrictions
Safety not established in children.
- Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Not recommended.
Precautions and warnings
regular eye examinations recommended; monitor for bleeding; use with caution in liver disease
Serious side effects
maculopathy — requires immediate medical attention; rectal haemorrhage — requires immediate medical attention; thrombocytopenia — requires immediate medical attention
Patient summary
Product utilized to address interstitial cystitis and indicated to support the bladder lining by reducing pain and discomfort.
Mechanism of action
This medicine acts as a heparin-like compound that adheres to the bladder wall mucosal membrane, creating a protective layer that limits irritation from urine components.
Elmiron
Product utilized to address interstitial cystitis and indicated to support the bladder lining by reducing pain and discomfort.
Editorial Notes
- Active ingredient(s): Pentosan Polysulfate
- Listed indication(s): Interstitial Cystitis
Available option
- 30 tablets - 100 mg1059-100-mg-17417